Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Lautrette

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
Blood|September 19, 2019
Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survivalRenaud Prevel, Claire Roubaud-Baudron, Samuel Gourlain, et al.
Intensive Care Medicine|April 13, 2026
Prophylactic noninvasive ventilation after extubation in high-risk patients without hypercapniaArnaud W Thille, Louis Chamblet, Stéphanie Ragot, et al.
JAMA|October 26, 2018
Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical TrialElie Azoulay, Virginie Lemiale, Djamel Mokart, et al.
The New England Journal of Medicine|October 26, 2022
Spontaneous-Breathing Trials with Pressure-Support Ventilation or a T-PieceArnaud W Thille, Arnaud Gacouin, Rémi Coudroy, et al.
Annals of Intensive Care|July 9, 2021
Correction to: Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failureVirginie Lemiale, Guillaume Dumas, Alexandre Demoule, et al.
Annals of Intensive Care|January 27, 2021
Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failureVirginie Lemiale, Guillaume Dumas, Alexandre Demoule, et al.
Transfusion|May 29, 2013
High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference CenterMarjolaine Morgand, Marc Buffet, Marc Busson, et al.
Trials|March 7, 2018
High-flow nasal oxygen vs. standard oxygen therapy in immunocompromised patients with acute respiratory failure: study protocol for a randomized controlled trialElie Azoulay, Virginie Lemiale, Djamel Mokart, et al.
BMJ Open|September 7, 2018
High-flow nasal cannula oxygen therapy alone or with non-invasive ventilation during the weaning period after extubation in ICU: the prospective randomised controlled HIGH-WEAN protocolArnaud W Thille, Grégoire Muller, Arnaud Gacouin, et al.
Critical Care (London, England)|September 8, 2019
Center effect in intubation risk in critically ill immunocompromised patients with acute hypoxemic respiratory failureGuillaume Dumas, Alexandre Demoule, Djamel Mokart, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Blood|September 19, 2019
Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survivalRenaud Prevel, Claire Roubaud-Baudron, Samuel Gourlain, et al.
Intensive Care Medicine|April 13, 2026
Prophylactic noninvasive ventilation after extubation in high-risk patients without hypercapniaArnaud W Thille, Louis Chamblet, Stéphanie Ragot, et al.
JAMA|October 26, 2018
Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical TrialElie Azoulay, Virginie Lemiale, Djamel Mokart, et al.
The New England Journal of Medicine|October 26, 2022
Spontaneous-Breathing Trials with Pressure-Support Ventilation or a T-PieceArnaud W Thille, Arnaud Gacouin, Rémi Coudroy, et al.
Annals of Intensive Care|July 9, 2021
Correction to: Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failureVirginie Lemiale, Guillaume Dumas, Alexandre Demoule, et al.
Annals of Intensive Care|January 27, 2021
Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failureVirginie Lemiale, Guillaume Dumas, Alexandre Demoule, et al.
Transfusion|May 29, 2013
High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference CenterMarjolaine Morgand, Marc Buffet, Marc Busson, et al.
Trials|March 7, 2018
High-flow nasal oxygen vs. standard oxygen therapy in immunocompromised patients with acute respiratory failure: study protocol for a randomized controlled trialElie Azoulay, Virginie Lemiale, Djamel Mokart, et al.
BMJ Open|September 7, 2018
High-flow nasal cannula oxygen therapy alone or with non-invasive ventilation during the weaning period after extubation in ICU: the prospective randomised controlled HIGH-WEAN protocolArnaud W Thille, Grégoire Muller, Arnaud Gacouin, et al.
Critical Care (London, England)|September 8, 2019
Center effect in intubation risk in critically ill immunocompromised patients with acute hypoxemic respiratory failureGuillaume Dumas, Alexandre Demoule, Djamel Mokart, et al.
Pageof 13